FERMENTA BIOTECH LTD. (FERMENTA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1951, Fermenta BiotechLtd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

FERMENTAUpdated 31 Aug 2026, 3:16

Fermenta Biotech Ltd.

Market Cap

₹1,501Cr.

Current Price

₹510

High / Low

₹580/249

Stock P/E

26.0

ROE13.8%
ROCE18.3%
Book Value₹144
Face Value₹5.00
Dividend Yield0.74%

About

Incorporated in 1951, Fermenta BiotechLtd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Aug 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days522685994951117592102112
Inventory Days347501392328317272235311
Days Payable172208135115150184160151
Cash Conversion Cycle52268234387352324242180177272
Working Capital Days-923-2,525-769-456422257392-192551122
ROCE %1%-5%-9%-7%45%13%14%10%4%4%20%18%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 3:16


Designed & Shipped by Harshit Bansal